Dashboard
1
With a growth in Operating Profit of 367.16%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 55.84 MM
- PRE-TAX PROFIT(Q) At CNY 12.36 MM has Grown at 270.62%
- NET PROFIT(Q) At CNY 11.06 MM has Grown at 252.04%
2
Market Beating performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
CNY 2,356 Million (Mid Cap)
219.00
NA
0.15%
-0.32
6.20%
2.25
Revenue and Profits:
Net Sales:
115 Million
(Quarterly Results - Mar 2026)
Net Profit:
11 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
55.42%
0%
55.42%
6 Months
135.39%
0%
135.39%
1 Year
187.53%
0%
187.53%
2 Years
371.42%
0%
371.42%
3 Years
247.8%
0%
247.8%
4 Years
243.04%
0%
243.04%
5 Years
0%
0%
0.0%
Inno Laser Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.37%
EBIT Growth (5y)
-31.55%
EBIT to Interest (avg)
-2.50
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.44
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
31.31%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.21%
ROE (avg)
3.60%
Valuation key factors
Factor
Value
P/E Ratio
219
Industry P/E
Price to Book Value
8.58
EV to EBIT
618.01
EV to EBITDA
188.79
EV to Capital Employed
11.29
EV to Sales
16.68
PEG Ratio
0.13
Dividend Yield
0.04%
ROCE (Latest)
1.83%
ROE (Latest)
3.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
115.20
85.00
35.53%
Operating Profit (PBDIT) excl Other Income
9.90
-1.90
621.05%
Interest
0.20
0.20
Exceptional Items
0.60
0.40
50.00%
Consolidate Net Profit
10.50
-7.50
240.00%
Operating Profit Margin (Excl OI)
85.70%
-137.30%
22.30%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 35.53% vs 8.28% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 240.00% vs 48.98% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
510.90
444.90
14.83%
Operating Profit (PBDIT) excl Other Income
60.70
31.60
92.09%
Interest
1.00
1.10
-9.09%
Exceptional Items
-6.40
0.10
-6,500.00%
Consolidate Net Profit
46.90
17.80
163.48%
Operating Profit Margin (Excl OI)
41.20%
-24.40%
6.56%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 14.83% vs 21.52% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 163.48% vs 435.85% in Dec 2024
About Inno Laser Technology Co., Ltd. 
Inno Laser Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






